Insider Transactions
| Date | Name | Title | Type | Filing | Shares Traded | Price Range | Total Held |
|---|---|---|---|---|---|---|---|
| Jan 15, 2020 | Chief Medical Officer | Open market or private sale of non-derivative or derivative security | Form 4 | 20,720 | $10.35 | 156,473 | |
| Jan 15, 2021 | Chief Legal Officer | Grant, award or other acquisition pursuant to Rule 16b-3(d) | Form 4 | 20,731 | -- | 229,499 | |
| Jul 27, 2016 | Chief Medical Officer | Open market or private sale of non-derivative or derivative security | Form 4 | 20,916 | $7.00 | 25,458 | |
| Aug 05, 2021 | Director, Chief Operating Officer | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Form 4 | 21,028 | $4.38 | 478,296 | |
| Aug 05, 2021 | Director, Chief Operating Officer | Open market or private sale of non-derivative or derivative security | Form 4 | 21,028 | $10.02 | 457,268 | |
| Aug 05, 2021 | Director, Chief Operating Officer | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Form 4 | 21,028 | -- | 45,060 | |
| Feb 05, 2008 | Ten Percent Owner | Open market or private purchase of non-derivative or derivative security | Form 4 | 21,246 | $10.20 | 451,936 | |
| Feb 05, 2008 | Director, Ten Percent Owner | Open market or private purchase of non-derivative or derivative security | Form 4 | 21,246 | $10.20 | 451,936 | |
| Jan 06, 2023 | Chief People Officer | Open market or private sale of non-derivative or derivative security | Form 4 | 21,507 | $11.87 | 219,566 | |
| Feb 01, 2024 | Director, Executive Chairman | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | Form 4 | 21,596 | $12.67 | 729,242 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.